Skip to main content
Erschienen in: Pediatric Nephrology 4/2010

01.04.2010 | Review

Effects of GH in human muscle and fat

verfasst von: Jens Otto Lunde Jørgensen, Kristine Z. Rubeck, Thomas S. Nielsen, Berthil F. F. Clasen, Mikkel Vendelboe, Thomas K. Hafstrøm, Michael Madsen, Sten Lund

Erschienen in: Pediatric Nephrology | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Skeletal muscle is the major constituent of lean body mass and a major determinant of energy expenditure both at rest and during physical activity. Growth hormone, in turn, influences muscle mass as well as energy expenditure. Growth hormone substitution in adults increases muscle mass by 5–10%, but part of the effect is attributed to rehydration rather than protein accretion. In addition, GH regulates substrate metabolism in muscle and in particular antagonizes insulin-stimulated glucose disposal. This effect is linked to increased free fatty acid (FFA) flux but the molecular mechanisms remain unclear. During fasting, GH-induced insulin resistance may be favorable by reducing the demand of gluconeogenesis from protein. But in the postprandial phase, GH exposure may compromise glucose tolerance via the same mechanisms. Understanding the mechanisms whereby GH antagonizes insulin-stimulated glucose disposal in muscle is an important future research field with implications for a variety of clinical conditions ranging from malnutrition to obesity and type 2 diabetes.
Literatur
1.
Zurück zum Zitat Ravussin E, Bogardus C (1989) Relationship of genetics, age, and physical fitness to daily energy expenditure and fuel utilization. Am J Clin Nutr 49:968–975PubMed Ravussin E, Bogardus C (1989) Relationship of genetics, age, and physical fitness to daily energy expenditure and fuel utilization. Am J Clin Nutr 49:968–975PubMed
2.
Zurück zum Zitat Moller N, Jorgensen JOL (2009) Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30:152–177CrossRefPubMed Moller N, Jorgensen JOL (2009) Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30:152–177CrossRefPubMed
3.
Zurück zum Zitat Moller N, Schmitz O, Joorgensen JO, Astrup J, Bak JF, Christensen SE, Alberti KG, Weeke J (1992) Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy. J Clin Endocrinol Metab 74:1012–1019CrossRefPubMed Moller N, Schmitz O, Joorgensen JO, Astrup J, Bak JF, Christensen SE, Alberti KG, Weeke J (1992) Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy. J Clin Endocrinol Metab 74:1012–1019CrossRefPubMed
4.
Zurück zum Zitat Moller N, Moller J, Jorgensen JO, Ovesen P, Schmitz O, Alberti KG, Christiansen JS (1993) Impact of 2 weeks high dose growth hormone treatment on basal and insulin stimulated substrate metabolism in humans. Clin Endocrinol (Oxf) 39:577–581CrossRef Moller N, Moller J, Jorgensen JO, Ovesen P, Schmitz O, Alberti KG, Christiansen JS (1993) Impact of 2 weeks high dose growth hormone treatment on basal and insulin stimulated substrate metabolism in humans. Clin Endocrinol (Oxf) 39:577–581CrossRef
5.
Zurück zum Zitat Rabinowitz D, Klassen GA, Zierler KL (1965) Effect of human growth hormone on muscle and adipose tissue metabolism in the forearm of man. J Clin Invest 44:51–61CrossRefPubMed Rabinowitz D, Klassen GA, Zierler KL (1965) Effect of human growth hormone on muscle and adipose tissue metabolism in the forearm of man. J Clin Invest 44:51–61CrossRefPubMed
6.
Zurück zum Zitat Krag MB, Gormsen LC, Guo Z, Christiansen JS, Jensen MD, Nielsen S, Jorgensen JO (2007) Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics. Am J Physiol Endocrinol Metab 292:E920–E927CrossRefPubMed Krag MB, Gormsen LC, Guo Z, Christiansen JS, Jensen MD, Nielsen S, Jorgensen JO (2007) Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics. Am J Physiol Endocrinol Metab 292:E920–E927CrossRefPubMed
7.
Zurück zum Zitat Nielsen S, Moller N, Christiansen JS, Jorgensen JO (2001) Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure. Diabetes 50:2301–2308CrossRefPubMed Nielsen S, Moller N, Christiansen JS, Jorgensen JO (2001) Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure. Diabetes 50:2301–2308CrossRefPubMed
8.
Zurück zum Zitat Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI (1999) Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103:253–259CrossRefPubMed Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI (1999) Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103:253–259CrossRefPubMed
9.
Zurück zum Zitat Jessen N, Djurhuus CB, Jorgensen JO, Jensen LS, Moller N, Lund S, Schmitz O (2005) Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion. Am J Physiol Endocrinol Metab 288:E194–E199CrossRefPubMed Jessen N, Djurhuus CB, Jorgensen JO, Jensen LS, Moller N, Lund S, Schmitz O (2005) Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion. Am J Physiol Endocrinol Metab 288:E194–E199CrossRefPubMed
10.
Zurück zum Zitat Nielsen C, Gormsen LC, Jessen N, Pedersen SB, Moller N, Lund S, Jorgensen JO (2008) Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade. J Clin Endocrinol Metab 93:2842–2850CrossRefPubMed Nielsen C, Gormsen LC, Jessen N, Pedersen SB, Moller N, Lund S, Jorgensen JO (2008) Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade. J Clin Endocrinol Metab 93:2842–2850CrossRefPubMed
11.
Zurück zum Zitat Mooney RA, Senn J, Cameron S, Inamdar N, Boivin LM, Shang Y, Furlanetto RW (2001) Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance. J Biol Chem 276:25889–25893CrossRefPubMed Mooney RA, Senn J, Cameron S, Inamdar N, Boivin LM, Shang Y, Furlanetto RW (2001) Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance. J Biol Chem 276:25889–25893CrossRefPubMed
12.
Zurück zum Zitat Norrelund H, Moller N, Nair KS, Christiansen JS, Jorgensen JO (2001) Continuation of growth hormone (GH) substitution during fasting in GH-deficient patients decreases urea excretion and conserves protein synthesis. J Clin Endocrinol Metab 86:3120–3129CrossRefPubMed Norrelund H, Moller N, Nair KS, Christiansen JS, Jorgensen JO (2001) Continuation of growth hormone (GH) substitution during fasting in GH-deficient patients decreases urea excretion and conserves protein synthesis. J Clin Endocrinol Metab 86:3120–3129CrossRefPubMed
13.
Zurück zum Zitat Norrelund H, Nair KS, Jorgensen JO, Christiansen JS, Moller N (2001) The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown. Diabetes 50:96–104CrossRefPubMed Norrelund H, Nair KS, Jorgensen JO, Christiansen JS, Moller N (2001) The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown. Diabetes 50:96–104CrossRefPubMed
14.
Zurück zum Zitat Norrelund H, Nair KS, Nielsen S, Frystyk J, Ivarsen P, Jorgensen JO, Christiansen JS, Moller N (2003) The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone. J Clin Endocrinol Metab 88:4371–4378CrossRefPubMed Norrelund H, Nair KS, Nielsen S, Frystyk J, Ivarsen P, Jorgensen JO, Christiansen JS, Moller N (2003) The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone. J Clin Endocrinol Metab 88:4371–4378CrossRefPubMed
15.
Zurück zum Zitat Norrelund H, Djurhuus C, Jorgensen JO, Nielsen S, Nair KS, Schmitz O, Christiansen JS, Moller N (2003) Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients. Am J Physiol Endocrinol Metab 285:E737–E743PubMed Norrelund H, Djurhuus C, Jorgensen JO, Nielsen S, Nair KS, Schmitz O, Christiansen JS, Moller N (2003) Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients. Am J Physiol Endocrinol Metab 285:E737–E743PubMed
16.
Zurück zum Zitat Sadowski CL, Wheeler TT, Wang LH, Sadowski HB (2001) GH regulation of IGF-1 and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells. Endocrinology 142:3890–3900CrossRefPubMed Sadowski CL, Wheeler TT, Wang LH, Sadowski HB (2001) GH regulation of IGF-1 and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells. Endocrinology 142:3890–3900CrossRefPubMed
17.
Zurück zum Zitat Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, Leroith D (1999) Normal growth and development in the absence of hepatic insulin-like growth factor 1. Proc Natl Acad Sci USA 96:7324–7329CrossRefPubMed Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, Leroith D (1999) Normal growth and development in the absence of hepatic insulin-like growth factor 1. Proc Natl Acad Sci USA 96:7324–7329CrossRefPubMed
18.
Zurück zum Zitat Jorgensen JOL, Jessen N, Pedersen SB, Vestergaard E, Gormsen L, Lund SA, Billestrup N (2006) Growth hormone receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus. Am J Physiol Endocrinol Metab 291:E899–E905CrossRefPubMed Jorgensen JOL, Jessen N, Pedersen SB, Vestergaard E, Gormsen L, Lund SA, Billestrup N (2006) Growth hormone receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus. Am J Physiol Endocrinol Metab 291:E899–E905CrossRefPubMed
19.
Zurück zum Zitat Dominici FP, Argentino DP, Munoz MC, Miquet JG, Sotelo AI, Turyn D (2005) Influence of the crosstalk between growth hormone and insulin signalling on the modulation of insulin sensitivity. Growth Horm IGF Res 15:324–336CrossRefPubMed Dominici FP, Argentino DP, Munoz MC, Miquet JG, Sotelo AI, Turyn D (2005) Influence of the crosstalk between growth hormone and insulin signalling on the modulation of insulin sensitivity. Growth Horm IGF Res 15:324–336CrossRefPubMed
20.
Zurück zum Zitat Lanning NJ, Carter-Su C (2006) Recent advances in growth hormone signaling. Rev Endocr Metab Disord 7:225–235CrossRefPubMed Lanning NJ, Carter-Su C (2006) Recent advances in growth hormone signaling. Rev Endocr Metab Disord 7:225–235CrossRefPubMed
22.
Zurück zum Zitat Maison P, Griffin S, Nicoue-Beglah M, Haddad N, Balkau B, Chanson P (2004) Impact of Growth Hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. J Clin Endocrinol Metab 89:2192–2199CrossRefPubMed Maison P, Griffin S, Nicoue-Beglah M, Haddad N, Balkau B, Chanson P (2004) Impact of Growth Hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. J Clin Endocrinol Metab 89:2192–2199CrossRefPubMed
23.
Zurück zum Zitat Richelsen B, Pedersen SB, Borglum JD, Moller-Pedersen T, Jorgensen J, Jorgensen JO (1994) Growth hormone treatment of obese women for 5 wk: effect on body composition and adipose tissue LPL activity. Am J Physiol 266:E211–E216PubMed Richelsen B, Pedersen SB, Borglum JD, Moller-Pedersen T, Jorgensen J, Jorgensen JO (1994) Growth hormone treatment of obese women for 5 wk: effect on body composition and adipose tissue LPL activity. Am J Physiol 266:E211–E216PubMed
24.
Zurück zum Zitat Jorgensen JO, Vahl N, Hansen TB, Thuesen L, Hagen C, Christiansen JS (1996) Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition. Clin Endocrinol (Oxf) 45:681–688CrossRef Jorgensen JO, Vahl N, Hansen TB, Thuesen L, Hagen C, Christiansen JS (1996) Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition. Clin Endocrinol (Oxf) 45:681–688CrossRef
25.
Zurück zum Zitat Zimmermann R, Strauss JG, Haemmerle G, Schoiswohl G, Birner-Gruenberger R, Riederer M, Lass A, Neuberger G, Eisenhaber F, Hermetter A, Zeclhner R (2004) Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306:1383–1386CrossRefPubMed Zimmermann R, Strauss JG, Haemmerle G, Schoiswohl G, Birner-Gruenberger R, Riederer M, Lass A, Neuberger G, Eisenhaber F, Hermetter A, Zeclhner R (2004) Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306:1383–1386CrossRefPubMed
26.
Zurück zum Zitat Jorgensen JO, Moller J, Alberti KG, Schmitz O, Christiansen JS, Orskov H, Moller N (1993) Marked effects of sustained low growth hormone (GH) levels on day-to-day fuel metabolism: studies in GH-deficient patients and healthy untreated subjects. J Clin Endocrinol Metab 77:1589–1596CrossRefPubMed Jorgensen JO, Moller J, Alberti KG, Schmitz O, Christiansen JS, Orskov H, Moller N (1993) Marked effects of sustained low growth hormone (GH) levels on day-to-day fuel metabolism: studies in GH-deficient patients and healthy untreated subjects. J Clin Endocrinol Metab 77:1589–1596CrossRefPubMed
27.
Zurück zum Zitat Moller J, Jorgensen JO, Moller N, Christiansen JS, Weeke J (1992) Effects of growth hormone administration on fuel oxidation and thyroid function in normal man. Metabolism 41:728–731CrossRefPubMed Moller J, Jorgensen JO, Moller N, Christiansen JS, Weeke J (1992) Effects of growth hormone administration on fuel oxidation and thyroid function in normal man. Metabolism 41:728–731CrossRefPubMed
28.
Zurück zum Zitat Moller L, Dalman L, Norrelund H, Billestrup N, Frystyk J, Moller N, Jorgensen JOL (2008) Impact of fasting on growth hormone signaling and action in muscle and fat. J Clin Endocrinol Metab 94:965–972CrossRefPubMed Moller L, Dalman L, Norrelund H, Billestrup N, Frystyk J, Moller N, Jorgensen JOL (2008) Impact of fasting on growth hormone signaling and action in muscle and fat. J Clin Endocrinol Metab 94:965–972CrossRefPubMed
29.
Zurück zum Zitat Moller N, Jorgensen JO, Alberti KG, Flyvbjerg A, Schmitz O (1990) Short-term effects of growth hormone on fuel oxidation and regional substrate metabolism in normal man. J Clin Endocrinol Metab 70:1179–1186CrossRefPubMed Moller N, Jorgensen JO, Alberti KG, Flyvbjerg A, Schmitz O (1990) Short-term effects of growth hormone on fuel oxidation and regional substrate metabolism in normal man. J Clin Endocrinol Metab 70:1179–1186CrossRefPubMed
30.
Zurück zum Zitat Leung KC, Ho KK (1997) Stimulation of mitochondrial fatty acid oxidation by growth hormone in human fibroblasts. J Clin Endocrinol Metab 82:4208–4213CrossRefPubMed Leung KC, Ho KK (1997) Stimulation of mitochondrial fatty acid oxidation by growth hormone in human fibroblasts. J Clin Endocrinol Metab 82:4208–4213CrossRefPubMed
31.
Zurück zum Zitat Richelsen BR, Pedersen SB, Kristensen K, Borglum JD, Norrelund H, Christiansen JS, Jorgensen JOL (2000) Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients. Metabolism 49:906–911CrossRefPubMed Richelsen BR, Pedersen SB, Kristensen K, Borglum JD, Norrelund H, Christiansen JS, Jorgensen JOL (2000) Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients. Metabolism 49:906–911CrossRefPubMed
32.
Zurück zum Zitat Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785–789CrossRefPubMed Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785–789CrossRefPubMed
33.
Zurück zum Zitat Norrelund H (2005) The metabolic role of growth hormone in humans with particular reference to fasting. Growth Horm IGF Res 15:95–122CrossRefPubMed Norrelund H (2005) The metabolic role of growth hormone in humans with particular reference to fasting. Growth Horm IGF Res 15:95–122CrossRefPubMed
Metadaten
Titel
Effects of GH in human muscle and fat
verfasst von
Jens Otto Lunde Jørgensen
Kristine Z. Rubeck
Thomas S. Nielsen
Berthil F. F. Clasen
Mikkel Vendelboe
Thomas K. Hafstrøm
Michael Madsen
Sten Lund
Publikationsdatum
01.04.2010
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 4/2010
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-009-1334-3

Weitere Artikel der Ausgabe 4/2010

Pediatric Nephrology 4/2010 Zur Ausgabe

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO2. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Zeitschrift für Allgemeinmedizin, DEGAM

Embryotransfer erhöht womöglich Leukämierisiko der Kinder

13.05.2024 Assistierte Reproduktion Nachrichten

Reproduktionsmedizinische Techniken haben theoretisch das Potenzial, den epigenetischen Code zu verändern und somit das Krebsrisiko der Kinder zu erhöhen. Zwischen Embryotransfer und Leukämie scheint sich ein solcher Zusammenhang bestätigt zu haben.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.